• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用未分级肝素固定、不根据体重调整的负荷剂量进行体外心肺复苏。

Use of a fixed, body weight-unadjusted loading dose of unfractionated heparin for extracorporeal cardiopulmonary resuscitation.

机构信息

Emergency and Critical Care Center, Mie University Hospital, Edobashi 2-174, Tsu, Mie Japan.

出版信息

J Intensive Care. 2015 Jul 21;3(1):33. doi: 10.1186/s40560-015-0098-z. eCollection 2015.

DOI:10.1186/s40560-015-0098-z
PMID:26199730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4508880/
Abstract

BACKGROUND

Extracorporeal cardiopulmonary resuscitation (ECPR) is being used increasingly in the emergency and critical care field in Japan. A major complication of ECPR is bleeding; however, the optimal initial heparin dose and activated coagulation time (ACT) remain unknown. The aim of this study was to assess the appropriateness of our initial anticoagulation protocol.

METHODS

We retrospectively evaluated the initial heparin dose, ACT value, and incidence of bleeding and thrombotic complications in post-cardiopulmonary arrest patients who received a fixed, body weight-unadjusted loading dose of unfractionated heparin (3000 U) prior to veno-arterial extracorporeal membrane oxygenator (ECMO) between February 2011 and November 2013 at Mie University Hospital, Japan.

RESULTS

ACT was evaluated within 3 h of initiation of 32 consecutive ECPR patients. The mean heparin dose per body weight was 53.6 U/kg and the mean ACT was 231.3 s. In 17 patients, ACT exceeded 200 s. Three patients experienced fatal bleeding in the chest wall within 24 h of receiving ECMO. The mean heparin dose per kilogram body weight, mean initial ACT, and mean duration of cardiopulmonary resuscitation (CPR) did not statistically differ between the patients who experienced fatal bleeding and those who did not.

CONCLUSIONS

Fixed-dose heparin of 3000-U bolus resulted in a mean heparin dose per kilogram body weight of 53.6 U/kg and an ACT of 231.3 s and experienced 3 out of 32 fatal bleedings. Further researches are warranted to optimize anticoagulation protocol for ECPR patients.

摘要

背景

体外心肺复苏(ECPR)在日本的急救和重症监护领域的应用越来越多。ECPR 的主要并发症是出血;然而,最佳的初始肝素剂量和激活凝血时间(ACT)仍不清楚。本研究旨在评估我们初始抗凝方案的适宜性。

方法

我们回顾性评估了 2011 年 2 月至 2013 年 11 月期间在日本三重大学医院接受静脉-动脉体外膜氧合(ECMO)前给予固定、未调整体重的普通肝素(3000U)负荷剂量的心肺复苏后患者的初始肝素剂量、ACT 值以及出血和血栓并发症的发生率。

结果

在 32 例连续接受 ECPR 的患者中,在开始治疗后 3 小时内评估了 ACT。每公斤体重的平均肝素剂量为 53.6U/kg,平均 ACT 为 231.3s。在 17 例患者中,ACT 超过 200s。3 例患者在接受 ECMO 后 24 小时内发生致命性胸壁出血。发生致命性出血的患者与未发生致命性出血的患者的每公斤体重肝素剂量、初始 ACT 均值和心肺复苏(CPR)持续时间均无统计学差异。

结论

3000U 负荷剂量的普通肝素导致每公斤体重肝素剂量为 53.6U/kg,ACT 为 231.3s,32 例患者中有 3 例发生致命性出血。需要进一步研究来优化 ECPR 患者的抗凝方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5538/4508880/cfd2e1426725/40560_2015_98_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5538/4508880/85ce2c8ec1fe/40560_2015_98_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5538/4508880/cfd2e1426725/40560_2015_98_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5538/4508880/85ce2c8ec1fe/40560_2015_98_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5538/4508880/cfd2e1426725/40560_2015_98_Fig2_HTML.jpg

相似文献

1
Use of a fixed, body weight-unadjusted loading dose of unfractionated heparin for extracorporeal cardiopulmonary resuscitation.使用未分级肝素固定、不根据体重调整的负荷剂量进行体外心肺复苏。
J Intensive Care. 2015 Jul 21;3(1):33. doi: 10.1186/s40560-015-0098-z. eCollection 2015.
2
Neurological outcomes and duration from cardiac arrest to the initiation of extracorporeal membrane oxygenation in patients with out-of-hospital cardiac arrest: a retrospective study.院外心脏骤停患者体外膜肺氧合启动与心脏骤停至开始之间的神经系统结局和持续时间:一项回顾性研究。
Scand J Trauma Resusc Emerg Med. 2017 Sep 16;25(1):95. doi: 10.1186/s13049-017-0440-7.
3
Heparin Loading Dose in Patients Undergoing Extracorporeal Cardiopulmonary Resuscitation.行体外心肺复苏的患者肝素初始负荷剂量。
J Cardiothorac Vasc Anesth. 2023 Jul;37(7):1201-1207. doi: 10.1053/j.jvca.2023.02.003. Epub 2023 Feb 22.
4
Chest compression-related fatal internal mammary artery injuries manifesting after venoarterial extracorporeal membrane oxygenation: a case series.体外膜肺氧合术后出现的与胸外按压相关的致命性胸廓内动脉损伤:病例系列报道
J Med Case Rep. 2017 Nov 11;11(1):318. doi: 10.1186/s13256-017-1485-y.
5
ECMO Cardio-Pulmonary Resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years.体外膜肺氧合心肺复苏(ECPR):一项为期12年的国际多中心队列研究中的生存趋势
Resuscitation. 2017 Mar;112:34-40. doi: 10.1016/j.resuscitation.2016.12.009. Epub 2016 Dec 16.
6
Thrombolytic-Enhanced Extracorporeal Cardiopulmonary Resuscitation After Prolonged Cardiac Arrest.长时间心脏骤停后溶栓增强的体外心肺复苏
Crit Care Med. 2016 Feb;44(2):e58-69. doi: 10.1097/CCM.0000000000001305.
7
Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation (eCPR).低血流时间对体外心肺复苏(eCPR)后生存的影响。
Crit Care. 2017 Jun 22;21(1):157. doi: 10.1186/s13054-017-1744-8.
8
Comparison of Extracorporeal Cardiopulmonary Resuscitation with Conventional Cardiopulmonary Resuscitation: Is Extracorporeal Cardiopulmonary Resuscitation Beneficial?体外心肺复苏与传统心肺复苏的比较:体外心肺复苏有益吗?
Korean J Thorac Cardiovasc Surg. 2015 Oct;48(5):318-27. doi: 10.5090/kjtcs.2015.48.5.318. Epub 2015 Oct 5.
9
Activated clotting time test alone is inadequate to optimize therapeutic heparin dosage adjustment during post-cardiopulmonary resuscitational extracorporeal membrane oxygenation (e-CPR).在心肺复苏后体外膜肺氧合(e-CPR)期间,仅激活凝血时间测试不足以优化肝素治疗剂量的调整。
Perfusion. 2016 May;31(4):307-15. doi: 10.1177/0267659115604710. Epub 2015 Sep 9.
10
Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.体外膜肺氧合支持下儿童抗凝管理的抗Xa因子导向方案
ASAIO J. 2015 May-Jun;61(3):339-44. doi: 10.1097/MAT.0000000000000204.

引用本文的文献

1
Anticoagulation and associated complications in veno-arterial extracorporeal membrane oxygenation in adult patients: A systematic review and meta-analysis.成人患者静脉-动脉体外膜肺氧合中的抗凝及相关并发症:一项系统评价和荟萃分析
Crit Care Resusc. 2024 Nov 26;26(4):332-363. doi: 10.1016/j.ccrj.2024.10.003. eCollection 2024 Dec.
2
Risk factors for bleeding complications in patients undergoing extracorporeal cardiopulmonary resuscitation following out-of-hospital cardiac arrest: a secondary analysis of the SAVE-J II study.院外心脏骤停后接受体外心肺复苏患者出血并发症的危险因素:SAVE-J II研究的二次分析
Ann Intensive Care. 2024 Jan 28;14(1):16. doi: 10.1186/s13613-024-01253-x.
3

本文引用的文献

1
Computed tomography findings of complications resulting from cardiopulmonary resuscitation.心肺复苏后并发症的计算机断层扫描表现。
Resuscitation. 2015 Mar;88:86-91. doi: 10.1016/j.resuscitation.2014.12.022. Epub 2015 Jan 8.
2
Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations.不同临床表现经皮冠状动脉介入治疗后主要出血的发生率及相关因素。
Am Heart J. 2014 Sep;168(3):248-55. doi: 10.1016/j.ahj.2014.05.018. Epub 2014 Jun 11.
3
Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with out-of-hospital cardiac arrest: a prospective observational study.
Understanding the "extracorporeal membrane oxygenation gap" in veno-arterial configuration for adult patients: Timing and causes of death.
了解成人患者静脉-动脉配置中的“体外膜氧合间隙”:死亡时间和原因。
Artif Organs. 2021 Oct;45(10):1155-1167. doi: 10.1111/aor.14006. Epub 2021 Jul 6.
4
Extracorporeal Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrest in Adult Patients.体外心肺复苏术在成人院外心脏骤停中的应用。
J Am Heart Assoc. 2020 Apr 7;9(7):e015291. doi: 10.1161/JAHA.119.015291. Epub 2020 Mar 24.
体外心肺复苏与常规心肺复苏治疗院外心脏骤停成人患者的前瞻性观察研究。
Resuscitation. 2014 Jun;85(6):762-8. doi: 10.1016/j.resuscitation.2014.01.031. Epub 2014 Feb 12.
4
Deeper chest compression - more complications for cardiac arrest patients?深度胸部按压——会增加心搏骤停患者的并发症吗?
Resuscitation. 2013 Jun;84(6):760-5. doi: 10.1016/j.resuscitation.2013.02.015. Epub 2013 Mar 5.
5
Heparin-free management of intra-aortic balloon pump after cardiac surgery.心脏手术后主动脉内球囊泵的无肝素管理
J Card Surg. 2012 Jul;27(4):434-7. doi: 10.1111/j.1540-8191.2012.01484.x.
6
Is heparin needed for patients with an intra-aortic balloon pump?使用主动脉内球囊反搏的患者需要肝素吗?
Interact Cardiovasc Thorac Surg. 2012 Jul;15(1):136-9. doi: 10.1093/icvts/ivs017. Epub 2012 Apr 11.
7
Thromboembolic events in patients on extracorporeal membrane oxygenation without anticoagulation.接受体外膜肺氧合治疗且未进行抗凝的患者发生血栓栓塞事件。
Innovations (Phila). 2010 Nov;5(6):424-9. doi: 10.1177/155698451000500608.
8
Use of nafamostat mesilate as an anticoagulant during extracorporeal membrane oxygenation.使用甲磺酸萘莫司他作为体外膜肺氧合期间的抗凝剂。
J Korean Med Sci. 2011 Jul;26(7):945-50. doi: 10.3346/jkms.2011.26.7.945. Epub 2011 Jun 20.
9
Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.第1部分:执行摘要:2010年心肺复苏与心血管急救科学及治疗建议国际共识。
Circulation. 2010 Oct 19;122(16 Suppl 2):S250-75. doi: 10.1161/CIRCULATIONAHA.110.970897.
10
Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.第一部分:执行摘要:2010 年美国心脏协会心肺复苏和紧急心血管护理指南。
Circulation. 2010 Nov 2;122(18 Suppl 3):S640-56. doi: 10.1161/CIRCULATIONAHA.110.970889.